Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	13.08	6.7	37.14	90.77	116.74	20.05
Short-Term Investments	1.5	27.56	26.58	-	-	-
Cash & Short-Term Investments	14.58	34.26	63.72	90.77	116.74	20.05
Cash Growth	-63.83%	-46.24%	-29.79%	-22.25%	482.20%	-2.88%
Accounts Receivable	0.26	0.49	0.18	0.59	-	-
Other Receivables	0.08	0.14	-	0.36	-	-
Receivables	0.34	0.63	0.18	0.94	-	-
Prepaid Expenses	0.53	1.17	3.39	1.14	1.27	0.74
Total Current Assets	15.45	36.06	67.29	92.85	118	20.79
Property, Plant & Equipment	0.15	0.26	0.09	0.08	0.04	0.19
Other Long-Term Assets	-	0.41	1.27	0.66	0.77	0.77
Total Assets	15.6	36.73	68.65	93.59	118.81	21.74
Accounts Payable	1.2	1.15	2.92	1.96	1.14	0.87
Accrued Expenses	5.06	3.88	4.68	3.43	3.03	2.71
Current Portion of Leases	0.19	0.17	0.09	0.08	0.04	0.1
Current Unearned Revenue	-	-	-	-	1.63	3.64
Other Current Liabilities	-	-	-	-	0.01	0.02
Total Current Liabilities	6.45	5.2	7.68	5.47	5.86	7.34
Long-Term Leases	-	0.15	-	-	-	0.09
Other Long-Term Liabilities	-	1.33	-	-	-	-
Total Liabilities	6.45	6.68	7.68	5.47	5.86	7.43
Common Stock	0	0	0	0.05	0.05	0.02
Additional Paid-In Capital	232.33	227.83	219.26	202.2	195.7	79.87
Retained Earnings	-223.19	-197.78	-158.3	-114.13	-82.8	-65.57
Comprehensive Income & Other	0	0	0.01	-	-	-
Total Common Equity	9.15	30.05	60.97	88.12	112.95	14.31
Shareholders' Equity	9.15	30.05	60.97	88.12	112.95	14.31
Total Liabilities & Equity	15.6	36.73	68.65	93.59	118.81	21.74
Total Debt	0.19	0.32	0.09	0.08	0.04	0.19
Net Cash (Debt)	14.39	33.94	63.64	90.69	116.7	19.86
Net Cash Growth	-64.00%	-46.67%	-29.83%	-22.29%	487.57%	-3.80%
Net Cash Per Share	4.86	11.54	24.20	36.78	114.94	38.46
Filing Date Shares Outstanding	2.96	2.96	2.94	2.47	2.46	0.77
Total Common Shares Outstanding	2.96	2.95	2.87	2.47	2.44	0.77
Working Capital	8.99	30.86	59.61	87.39	112.15	13.45
Book Value Per Share	3.09	10.19	21.22	35.66	46.29	18.60
Tangible Book Value	9.15	30.05	60.97	88.12	112.95	14.31
Tangible Book Value Per Share	3.09	10.19	21.22	35.66	46.29	18.60

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q